Shilpa Medicare Limited (BOM:530549)
550.70
+4.95 (0.91%)
At close: Jun 19, 2026
Shilpa Medicare Revenue
In the fiscal year ending March 31, 2026, Shilpa Medicare had annual revenue of 15.39B INR with 19.49% growth. Shilpa Medicare had revenue of 4.37B in the quarter ending March 31, 2026, with 31.51% growth.
Revenue
15.39B
Revenue Growth
+19.49%
P/S Ratio
7.00
Revenue / Employee
15.42M
Employees
998
Market Cap
107.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 15.39B | 2.51B | 19.49% |
| Mar 31, 2025 | 12.88B | 1.35B | 11.69% |
| Mar 31, 2024 | 11.53B | 1.01B | 9.64% |
| Mar 31, 2023 | 10.52B | -952.56M | -8.31% |
| Mar 31, 2022 | 11.47B | 2.45B | 27.21% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IOL Chemicals and Pharmaceuticals | 23.19B |
| Neuland Laboratories | 20.23B |
| Bajaj HealthCare | 6.11B |
| NGL Fine-Chem | 5.01B |
| Aarey Drugs & Pharmaceuticals | 4.72B |
| Sai Parenteral's | 3.81B |
| Anlon Healthcare | 1.72B |
| Gujarat Themis Biosyn | 1.66B |
Shilpa Medicare News
- 13 days ago - Shilpa Medicare and Gate2brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy - Business Upturn
- 18 days ago - Shilpa Medicare subsidiary invests €7 million for 30.4% stake in Gate2Brain - Business Upturn
- 4 weeks ago - Shilpa Medicare Q4 Results: Net profit jumps over 7x to Rs 108 crore, revenue up 32% - Business Upturn
- 2 months ago - Pharma sector stocks today, April 6: Shilpa Medicare down 3.07%, Ipca Labs decline 2.42%, Sun Pharma falls 1.42% - Business Upturn
- 3 months ago - Pharma sector stocks today, March 24: Shilpa Medicare jumps 3.28%, Glenmark Pharma up 1.36%, Laurus Labs gain 1.65% - Business Upturn
- 3 months ago - Pharma sector stocks today, March 6: Shilpa Medicare surge 3.08%, Wockhardt jumps 2.12%, Natco Pharma up 1.84%, - Business Upturn
- 4 months ago - Shilpa Medicare signs strategic licensing agreement with SteinCares to commercialize biosimilar in Latin America - Business Upturn
- 4 months ago - Pharma sector stocks today, Feb 9: Marksans Pharma up 5%, Shilpa Medicare jumps 6%, Glenmark rises 1.83% - Business Upturn